ClinVar Miner

Submissions for variant NM_000441.2(SLC26A4):c.1204G>A (p.Val402Met) (rs397516414)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Hearing Loss Variant Curation Expert Panel RCV001171536 SCV001334321 pathogenic Pendred syndrome 2020-02-19 reviewed by expert panel curation The p.Val402Met variant in SLC26A4 was absent from gnomAD v2.1.1 and v3 (PM2). This variant has been detected in 2 probands with hearing loss. For both patients, a pathogenic or suspected-pathogenic variant was observed in trans (PM3_Strong, PMID:19204907, Partners LMM unpublished data SCV000060082.6). The variant has been reported to segregate in one affected family member (PP1, PMID:19204907). At least one proband with this variant displayed features of sensorineural hearing loss and enlarged vestibular aqueduct, a phenotype specific for Pendred syndrome (PP4, LMM unpublished data SCV000060082.6). Functional studies including fluorescence assays have demonstrated that this variant impacts protein function (PS3_Supporting; PMID:19204907). The REVEL computational prediction analysis tool produced a score of 0.77, which is above the threshold necessary to apply PP3. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Pendred syndrome based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel (PM3_Strong, PM2, PP1, PP3, PP4, PS3_Supporting).
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000036427 SCV000060082 likely pathogenic Rare genetic deafness 2016-11-17 criteria provided, single submitter clinical testing The p.Val402Met variant in SLC26A4 has been identified in the compound heterozyg ous state with another pathogenic variant in SLC26A4 in two siblings with enlarg ed vestibular aqueduct (Choi 2009) and in an individual with hearing loss tested by our laboratory. This variant has not been reported in large population studi es. A study has shown that the p.Val402Met variant may impact protein function ( Choi 2009). In summary, although additional studies are required to fully establ ish its clinical significance, this variant is likely pathogenic.
Illumina Clinical Services Laboratory,Illumina RCV000259862 SCV000466100 uncertain significance SLC26A4-Related Disorders 2016-07-27 criteria provided, single submitter clinical testing The SLC26A4 c.1204G>A (p.Val402Met) variant is a missense variant that has been reported in one study, in which it was found in a compound heterozygous state with a second missense variant in two siblings with hearing loss and bilateral enlarged vestibular aqueduct (Choi et al. 2009). The p.Val402Met variant was absent from 172 ethnically matched control chromosomes and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium despite being located in a region of good sequence coverage. Therefore, it is presumed to be rare. Functional studies in COS-7 cells demonstrated that the p.Val402Met variant protein showed improper cellular localization, with endoplasmic reticulum retention compared to the cell surface expression of the wild type protein. The Val402 residue is conserved among SLC26A4 orthologues but not among SLC26A4 paralogues. The evidence for this variant is limited. The p.Val402Met variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for SLC26A4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.